- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00599677
Randomized Controlled Trial of Acupuncture for Functional Dyspepsia
8. november 2011 opdateret af: Chengdu University of Traditional Chinese Medicine
The purpose of the study is to testify the efficacy of treating functional dyspepsia with acupuncture, and provide evidence for the hypothesis that "Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The purpose of the study is to testify whether acupuncture is effective for functional dyspepsia, through treating functional dyspepsia patient for a month, using different acupoints according to literatures of treating migraine with acupuncture, and using Itopride as controlled group, and try to provide clinical evidence for the hypothesis that"Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
720
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Sichuan
-
Chengdu, Sichuan, Kina, 610075
- Chengdu University of TCM
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 65 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Consistent with the diagnostic criteria of functional dyspepsia.
- Age of a subject is older than 18 and is younger than 65.(including 18 and 65)
- Did not take any gastroenteric dynamic drugs in the last 15 days, and did not take part in any clinical trial.
- Informed consent is signed by a subject or his lineal relation.
Exclusion Criteria:
- Patients with any contraindications of Itopride.
- Patients who are unconscious, psychotic.
- Patients with aggravating tumor and other serious consumptive disease, and who are subject to infection and bleeding.
- With serious protopathy or disease of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on.
- Pregnant women or women in lactation.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: group 1
specific acupoints of Stomach meridians
|
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
|
|
Eksperimentel: group 2
Non-specific acupoints of Stomach meridians
|
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
|
|
Eksperimentel: group 3
alarm and transport points
|
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
|
|
Eksperimentel: group 4
acupoints of the other meridian
|
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
|
|
Sham-komparator: group 5
non-acupoints
|
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
|
|
Aktiv komparator: group 6
Itopride
|
Each pill weighs 50mg, once a pill, three times a day.
The pills are taken half an hour before meals, and be taken 4 weeks continuously.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Nepean Dyspepsia Index
Tidsramme: 4 weeks
|
4 weeks
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Symptoms Index of Dyspepsia
Tidsramme: 4 weeks
|
4 weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Studiestol: Fan-rong Liang, master, Chengdu University of TCM
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Zhao L, Zhang FW, Li Y, Wu X, Zheng H, Cheng LH, Liang FR. Adverse events associated with acupuncture: three multicentre randomized controlled trials of 1968 cases in China. Trials. 2011 Mar 24;12:87. doi: 10.1186/1745-6215-12-87.
- Ma T, Zeng F, Li Y, Wang CM, Tian X, Yu S, Zhao L, Wu X, Yang M, Wang D, Liang F. Which subtype of functional dyspepsia patients responses better to acupuncture? A retrospective analysis of a randomized controlled trial. Forsch Komplementmed. 2015;22(2):94-100. doi: 10.1159/000380983. Epub 2015 Mar 11.
- Zheng H, Tian XP, Li Y, Liang FR, Yu SG, Liu XG, Tang Y, Yang XG, Yan J, Sun GJ, Chang XR, Zhang HX, Ma TT, Yu SY. Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial. Trials. 2009 Aug 23;10:75. doi: 10.1186/1745-6215-10-75.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. november 2007
Primær færdiggørelse (Faktiske)
1. september 2009
Studieafslutning (Faktiske)
1. september 2009
Datoer for studieregistrering
Først indsendt
4. januar 2008
Først indsendt, der opfyldte QC-kriterier
23. januar 2008
Først opslået (Skøn)
24. januar 2008
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
9. november 2011
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
8. november 2011
Sidst verificeret
1. november 2011
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2006CB5045012
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .